Cover Image
市場調查報告書

全球數位病理診斷系統市場

Digital Pathology Systems

出版商 Global Industry Analysts, Inc. 商品編碼 269628
出版日期 內容資訊 英文 175 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球數位病理診斷系統市場 Digital Pathology Systems
出版日期: 2015年01月01日 內容資訊: 英文 175 Pages
簡介

本報告提供全球數位病理診斷系統市場相關調查分析,提供您各產品區隔,地區(美國,加拿大,日本,歐洲,亞太地區,南美等)別之市場實際成果與預測,及包含主要企業簡介等之系統性資訊。

第1章 簡介·調查手法·產品定義

第2章 摘要整理

  • 產業概要
    • 不景氣的影響
    • 市場預測
    • 主要的問題點
    • 未來
  • 推動市場要素·趨勢·問題點
    • 組織分析自動化的必要性
    • 工作流程效率
    • 病理醫生的不足與過度的工作流程
    • 早期診斷的必要性
    • 臨床研究
    • 技術的進步
    • 數位病理診斷的可能性
    • 數位病理診斷系統
    • 癌症·慢性疾病的迅速引進
    • 託管技術轉移
    • 數位病理診斷這個服務,其他
  • 競爭
  • 產品概要
  • 產品的銷售/革新
  • 近來產業活動
  • 全球主要企業
    • 3DHISTECH Ltd.(匈牙利)
    • AccelPath, Inc.(美國)
    • Apollo PACS, Inc.(美國)
    • Carl Zeiss AG(德國)
    • Corista LLC(美國)
    • Definiens AG(德國)
    • DigiPath Inc.(美國)
    • Flagship Biosciences, LLC(美國)
    • Koninklijke Philips Electronics N.V.(荷蘭)
    • Leica Microsystems GmbH(德國)
    • MikroScan Technologies, Inc.(美國)
    • Olympus America, Inc.(美國)
    • Omnyx, LLC(美國)
    • Pixcelldata Ltd.(愛爾蘭)
    • Ventana Medical Systems, Inc.(美國)
    • VMscope GmbH(德國)
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

第4章 競爭情形

  • 競爭企業簡介:50公司(包含產業部/子公司的話54公司)
    • 美國
    • 加拿大
    • 日本
    • 歐洲
    • 日本以外的亞太地區

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6740

This report analyzes the worldwide markets for Digital Pathology Systems in US$ Thousands. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 50 companies including many key and niche players such as -

3DHISTECH Ltd.
AccelPath, Inc.
Apollo PACS, Inc.
Carl Zeiss AG
Corista LLC

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Prelude
  • Impact of Economic Recession in Retrospect & the Road Ahead
  • Market Outlook
  • Developed Markets to Maintain their Dominance
  • Digital Pathology Systems See Fast Paced Growth in Emerging Nations
  • Analytics: A Fast Growing Segment
  • Key Issues Hampering the Wider Adoption of Digital Pathology Systems
  • The Future in Retrospect

2. MARKET DRIVERS, TRENDS & ISSUES

  • The Need for Automation in Tissue Analysis
  • Workflow Efficiencies: A Key Market Driver for Digital Pathology Systems
  • Scarcity of Pathologists & Excess Workload on Pathology Labs Drives Demand for Digital Systems
  • Need for Early Diagnosis Puts Focus on Digital Pathology
  • Clinical Research Continues to be Core Vertical for Digital Pathology
  • Technological Advances Ease Issues in Digital Pathology Adoption
  • Possibilities Ahead in Digital Pathology
  • Digital Pathology Systems Continue to Widen their Scope
  • Digital Pathology Systems See Fast Paced Adoption in Cancer and Other Chronic Diseases
  • Move towards Hosted Technology: The New Fad
  • Digital Pathology as a Service Eludes Cost-based Issues
  • Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations
  • Rising Emphasis on Lab Automation Extends Opportunity for Digital Pathology
  • Rising Penetration of Personalized Medicine Bodes Well for Digital Pathology
  • Increased Focus on Companion Diagnostics to Benefit the Market
  • Improving Healthcare & Research Expenditures Turbo Charge Digital Pathology
    • Table 1: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)
    • Table 2: Top 20 Countries with the Highest Healthcare Spending as a Percentage of GDP (2012) (includes corresponding Graph/Chart)
  • Burgeoning Global Population: A Strong Business Case for Market Growth
    • Table 3: Top 25 Countries Worldwide in Terms of Population: 2007, 2010 & 2013 (includes corresponding Graph/Chart)
  • Aging Population: A Key Opportunity Indicator
    • Table 4: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
    • Table 5: Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart)
    • Table 6: Global Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Table 7: Aging Population by Age Group in More Developed Countries (1975-2050) (includes corresponding Graph/Chart)
    • Table 8: Aging Population by Age Group in Less Developed Countries (1975-2050) (includes corresponding Graph/Chart)
    • Table 9: Aging Population by Age Group in Least Developed Countries (1975-2050) (includes corresponding Graph/Chart)
    • Table 10: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
  • Key Issues Hampering the Wider Adoption of Digital Pathology Systems
  • High Costs
  • Workflow Integration with Other Related Functions
  • Other Issues

3. COMPETITION

  • Leica Dominates the Market
    • Table 11: Leading Players in the Global Digital Pathology Systems Market (2013): Percentage Breakdown of Dollar Sales for Leica, Olympus, Roche/Ventana and Others (includes corresponding Graph/Chart)
  • Consolidation Rife in the Digital Pathology Space

4. PRODUCT OVERVIEW

  • An Introduction to Pathology
  • Digital Pathology: Computer-Enabled Pathology Process
  • Digital Pathology System: Components
  • Slide Scanners
  • Analytics
  • Storage
  • Communication
  • Applications
  • Remote Reviewing
  • Digital-Assisted Mathematical Analysis
  • Data Storage
  • Telepathology
    • Static Telepathology
    • Dynamic Telepathology
    • Hybrid Telepathology
  • Bio-banking
  • Multinational Integration
  • Tissue Microarray Analysis
  • A Review of Information Archival and Retrieval in Digital Pathology
  • Storage and Interoperability
  • Location and Internal Communication
  • Systems and Data Reliability
  • Image Life-Cycle Management
  • IT infrastructure and Management Costs
  • Factors Affecting Information Archival
  • Digital Pathology Management Systems
  • Benefits of Digital Pathology Systems
  • Easier Analysis and Archival & Retrieval of Digital Images
  • Access to Digital Slide Images Anytime Anywhere

5. PRODUCT INTRODUCTIONS/INNOVATIONS

  • Philips Obtains CE Mark Approval for Diagnostic Use of its Philips Digital Pathology Solution
  • Mikroscan Technologies Unveils Mikroscan L6 and the Mikroscan MC2 Telepathology Systems
  • Royal Philips Receives FDA 510(k) Clearance for Her2/neu IHC Digital Manual Read Product
  • Ventana Medical Systems Launches iScan HT Slide Scanner
  • Ventana Obtains FDA 510(k) Clearance for VENTANA Companion Algorithm Ki-67 (30-9) Image Analysis Solution

6. RECENT INDUSTRY ACTIVITY

  • Visiopharm Begins Operations in Benelux
  • Pixcelldata Selects Edge Solutions as its US Partner
  • CellNetix Pathology and Laboratories Merges with Highline Pathology Associates
  • Definiens Teams Up with Clarient Diagnostic Services
  • Pixcelldata Signs Partnership Deal with eX-Path
  • Pixcelldata Inks Partnership Agreement with Basys Data
  • IDEXX Laboratories Inks Collaboration Agreement with Royal Philips
  • Ventana Medical Systems and EMC Join Hands
  • XIFIN Acquires PathCentral
  • Kanteron Systems Signs Joint Selling & Marketing Agreement with DigiPath
  • DigiPath Inks New Agreement with Personalized Diagnostic
  • Dako to Launch Clinical Image Analysis for Digital Pathology
  • Ventana Medical Systems Inks Global Agreement with Barco
  • MEDITE Teams Up with UNIC Technologies
  • Leica Biosystems Takes Over Aperio Technologies
  • Carl Zeiss MicroImaging and Olympus America Sign Licensing Agreement
  • Aperio Technologies and Dell Enter into Strategic Collaboration
  • AccelPath Acquires DigiPath Solutions
  • Leica Microsystems and Indica Labs Sign Agreement
  • Omnyx™ Receives CE Mark in Europe
  • Erasmus MC Selects Philips to Adopt Digital Pathology System

7. FOCUS ON SELECT GLOBAL PLAYERS

  • 3DHISTECH Ltd. (Hungary)
  • AccelPath, Inc. (US)
  • Apollo PACS, Inc. (US)
  • Carl Zeiss AG (Germany)
  • Corista LLC (US)
  • Definiens AG (Germany)
  • DigiPath Inc. (US)
  • Flagship Biosciences, LLC (US)
  • Koninklijke Philips Electronics N.V. (Netherlands)
  • Leica Microsystems GmbH (Germany)
  • MikroScan Technologies, Inc. (US)
  • Olympus America, Inc. (US)
  • Omnyx, LLC (US)
  • Pixcelldata Ltd. (Ireland)
  • Ventana Medical Systems, Inc. (US)
  • VMscope GmbH (Germany)

8. GLOBAL MARKET PERSPECTIVE

    • Table 12: World Recent Past, Current and Future Analysis for Digital Pathology Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for Digital Pathology Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 14: World 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Market Overview
    • Increasing Pressure on Pathological Labs - An Opportunity in Disguise
    • Regulatory Scenario in the US
      • Health Insurance Portability and Accountability Act (HIPAA)
      • Food and Drug Administration (FDA)
      • Clinical Laboratory Improvement Amendments (CLIA)
    • Approval Status
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 15: US Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 16: US Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Need for Digital Pathology in Canada
  • B. Market Analytics
    • Table 17: Canadian Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 18: Canadian Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Digital Pathology in Japan - An Overview
  • B. Market Analytics
    • Table 19: Japanese Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 20: Japanese Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 21: European Recent Past, Current and Future Analysis for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 22: European Historic Review for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 23: European 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 24: French Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 25: French Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 26: German Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 27: German Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 28: Italian Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 29: Italian Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 30: UK Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 31: UK Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 32: Spanish Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 33: Spanish Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 34: Russian Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 35: Russian Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 36: Rest of Europe Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 37: Rest of Europe Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Asia-Pacific: Gradually Embracing Telepathology
    • Market Exhibits Faster Growth
    • South Korea: Limited Adoption despite Adequate Networking Infrastructure
    • China: Static Telepathology Remains Popular
    • Inadequate Infrastructure Impedes Adoption of Digital Pathology in India
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 38: Asia-Pacific Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 39: Asia-Pacific Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 40: Latin American Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 41: Latin American Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Africa: Digital Pathology finds Few Takers
  • B. Market Analytics
    • Table 42: Rest of World Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 43: Rest of World Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top